Armata Pharmaceuticals, Inc.

Quick facts

Phase 2 pipeline

• AB-PA01 · Infectious Disease
  AB-PA01 is a bacteriophage therapeutic that targets and lyses pathogenic bacteria to treat infections.
• AB-SA01 · Infectious Diseases
  AB-SA01 is a novel antimicrobial agent that targets and disrupts bacterial cell membranes.
• AP-PA02
• C16G2 Gel
• C16G2 Rinse · Dermatology
  C16G2 Rinse is a topical antimicrobial agent.
• C16G2 Strip
• C16G2 Varnish

Phase 1 pipeline

• AP-SA02

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Armata Pharmaceuticals, Inc. portfolio CI brief
• Armata Pharmaceuticals, Inc. pipeline updates RSS